Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study
- Resource Type
- Short Survey
- Source
- In
Clinical Gastroenterology and Hepatology November 2023 21(12):3188-3190 - Subject
- Language
- ISSN
- 1542-3565